DBPR108 - CAS 1186426-66-3
Catalog number:
1186426-66-3
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C16H25FN4O2
Molecular Weight:
324.39
COA:
Inquire
Targets:
DPP4
Description:
DBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II. TThe in vivo effects of DBPR108, including inhibition of plasma DPP-IV activity and suppression of blood glucose elevation, were also demonstrated. DBPR108 is a potent, selective, long-acting and safe DPP-IV inhibitor as a potential treatment of type 2 diabetes mellitus.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
DBPR-108
MSDS:
Inquire
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related DPP4 Products


CAS 361442-04-8 Saxagliptin

Saxagliptin
(CAS: 361442-04-8)

Saxagliptin is a drug which was developed for the treatment of respiratory disorders such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It is oral...

CAS 852329-66-9 Dutogliptin

Dutogliptin
(CAS: 852329-66-9)

Dutogliptin is a selective and orally active DPP4 inhibitor. It can improve glycaemic control in patients with type 2 diabetes. But phase III clinical trials fo...

Evogliptin
(CAS: 1222102-29-5)

This active molecular is a selective dipeptidyl peptidase 4 (DPP4) inhibitor under the development of Dong-A. Evogliptin improves insulin resistance and delays ...

CAS 1186426-66-3 DBPR108

DBPR108
(CAS: 1186426-66-3)

DBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II. TThe in vivo effects of DBPR108, including ...

CAS 486460-32-6 Sitagliptin

Sitagliptin
(CAS: 486460-32-6)

Sitagliptin (MK 0431) is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts. Sitagliptin is used as a hypoglycemic agent to treat type 2 diab...

CAS 868771-57-7 Melogliptin

Melogliptin
(CAS: 868771-57-7)

Melogliptin is a selective dipeptidyl peptidase IV (DPP-IV) inhibitor. But No development was reported about Phase-II for Type-2 diabetes mellitus.

ASP-8497
(CAS: 651055-26-4)

ASP8497 is a long-acting and potent DPP-IV inhibitor. It improves glucose tolerance through glucose-dependent insulinotropic action via elevation of the GLP-1 l...

CAS 850649-62-6 ALOGLIPTIN BENZOATE

ALOGLIPTIN BENZOATE
(CAS: 850649-62-6)

Alogliptin benzoate(SYR 322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

CAS 850649-61-5 Alogliptin

Alogliptin
(CAS: 850649-61-5)

Alogliptin is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

CAS 150080-09-4 Talabostat mesylate

Talabostat mesylate
(CAS: 150080-09-4)

Talabostat mesylate is the orally bioavailable mesylate salt of an amino boronic dipeptide with antineoplastic and hematopoiesis- stimulating activities. By cle...

CAS 654671-78-0 Sitagliptin phosphate

Sitagliptin phosphate
(CAS: 654671-78-0)

Sitagliptin phosphate is a potent inhibitor of DPP4 in Caco-2 cell extracts.

CAS 869490-23-3 Gosogliptin

Gosogliptin
(CAS: 869490-23-3)

Gosogliptin is a dipeptidyl peptidase IV (DPP-IV) inhibitor. But no development was reported about Phase-II for Type-2 diabetes mellitus.

CAS 668270-12-0 Linagliptin

Linagliptin
(CAS: 668270-12-0)

A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.

ASP-8497 free base
(CAS: 651055-25-3)

ASP-8497 free base is a long-acting and potent DPP-IV inhibitor. It improves glucose tolerance through glucose-dependent insulinotropic action via elevation of ...

CAS 1029877-94-8 Trelagliptin succinate

Trelagliptin succinate
(CAS: 1029877-94-8)

Trelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).

CAS 654671-77-9 Sitagliptin phosphate monohydrate

Sitagliptin phosphate monohydrate
(CAS: 654671-77-9)

Sitagliptin phosphate is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts. It is used either alone or in combination with other oral anti...

CAS 865759-25-7 Trelagliptin

Trelagliptin
(CAS: 865759-25-7)

Two Phase II clinical studies have been completed with Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus. Phase III clinical studies with...

CAS 945667-22-1 Saxagliptin hydrate

Saxagliptin hydrate
(CAS: 945667-22-1)

Saxagliptin hydrate is a selective and reversible DPP4 inhibitor. It demonstrates greater specificity for DPP4 than for either the DPP8 or DPP9 enzymes. It redu...

CAS 760937-92-6 Teneligliptin

Teneligliptin
(CAS: 760937-92-6)

Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human recombinant ...

CAS 906093-29-6 Teneligliptin hydrobromide

Teneligliptin hydrobromide
(CAS: 906093-29-6)

Teneligliptin hydrobromide is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human...

Chemical Structure

CAS 1186426-66-3 DBPR108

Quick Inquiry

Verification code

Featured Items